Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

The Company plans to use up to $200.0 million of the net proceeds from the offering to repurchase shares of the Company's common stock, including up to approximately $143.1 million to repurchase approximately 8.1 million shares of its common stock concurrently with the offering in privately negotiated transactions effected through one or more of the initial purchasers or an affiliate thereof.

That sounds like Kirk. You nailed it.
-Fritz